Martine A Rothblatt is Chairperson & CEO of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 130 shares of UTHR, which is worth approximately $48,616. The most recent transaction as insider was on Nov 15, 2022, when has been sold 8,000 shares (Common Stock) at a price of $113.08 per share, resulting in proceeds of $904,640. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 130
0% 3M change
0% 12M change
Total Value Held $48,616

MARTINE A ROTHBLATT Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 15 2022
BUY
Exercise of conversion of derivative security
$904,640 $113.08 p/Share
8,000 Added 49.6%
8,130 Common Stock
Nov 14 2022
SELL
Open market or private sale
$2,069,440 $258.68 p/Share
8,000 Reduced 98.4%
130 Common Stock
Nov 14 2022
BUY
Exercise of conversion of derivative security
$904,640 $113.08 p/Share
8,000 Added 49.6%
8,130 Common Stock
Nov 11 2022
SELL
Open market or private sale
$2,060,880 $257.61 p/Share
8,000 Reduced 98.4%
130 Common Stock
Nov 11 2022
BUY
Exercise of conversion of derivative security
$904,640 $113.08 p/Share
8,000 Added 49.6%
8,130 Common Stock
Nov 10 2022
SELL
Open market or private sale
$2,102,320 $262.79 p/Share
8,000 Reduced 98.4%
130 Common Stock
Nov 10 2022
BUY
Exercise of conversion of derivative security
$904,640 $113.08 p/Share
8,000 Added 49.6%
8,130 Common Stock
Nov 09 2022
SELL
Open market or private sale
$2,112,560 $264.07 p/Share
8,000 Reduced 98.4%
130 Common Stock
Nov 09 2022
SELL
Open market or private sale
$84,457 $263.93 p/Share
320 Reduced 37.91%
524 Common Stock
Nov 09 2022
BUY
Exercise of conversion of derivative security
$904,640 $113.08 p/Share
8,000 Added 49.6%
8,130 Common Stock
Nov 08 2022
SELL
Open market or private sale
$2,025,676 $263.76 p/Share
7,680 Reduced 98.34%
130 Common Stock
Nov 08 2022
BUY
Exercise of conversion of derivative security
$904,640 $113.08 p/Share
8,000 Added 49.6%
8,130 Common Stock
Nov 07 2022
SELL
Open market or private sale
$2,133,360 $266.67 p/Share
8,000 Reduced 98.4%
130 Common Stock
Nov 07 2022
BUY
Exercise of conversion of derivative security
$904,640 $113.08 p/Share
8,000 Added 49.6%
8,130 Common Stock
Nov 04 2022
SELL
Open market or private sale
$2,124,720 $265.59 p/Share
8,000 Reduced 98.4%
130 Common Stock
Nov 04 2022
BUY
Exercise of conversion of derivative security
$904,640 $113.08 p/Share
8,000 Added 49.6%
8,130 Common Stock
Nov 03 2022
SELL
Open market or private sale
$2,106,320 $263.29 p/Share
8,000 Reduced 98.4%
130 Common Stock
Nov 03 2022
BUY
Exercise of conversion of derivative security
$904,640 $113.08 p/Share
8,000 Added 49.6%
8,130 Common Stock
Nov 02 2022
SELL
Open market or private sale
$1,986,640 $248.33 p/Share
8,000 Reduced 98.4%
130 Common Stock
Nov 02 2022
BUY
Exercise of conversion of derivative security
$904,640 $113.08 p/Share
8,000 Added 49.6%
8,130 Common Stock
Nov 01 2022
SELL
Open market or private sale
$1,848,400 $231.05 p/Share
8,000 Reduced 98.4%
130 Common Stock
Nov 01 2022
BUY
Exercise of conversion of derivative security
$904,640 $113.08 p/Share
8,000 Added 49.6%
8,130 Common Stock
Jun 02 2022
SELL
Open market or private sale
$131,416 $226.97 p/Share
579 Reduced 81.66%
130 Common Stock
Jun 02 2022
BUY
Exercise of conversion of derivative security
$30,930 $53.42 p/Share
579 Added 44.95%
709 Common Stock
Jun 01 2022
SELL
Open market or private sale
$692,730 $230.91 p/Share
3,000 Reduced 95.85%
130 Common Stock
MAR

Martine A Rothblatt

Chairperson & CEO
Silver Spring, MD

Track Institutional and Insider Activities on UTHR

Follow UNITED THERAPEUTICS Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR